A Phase II Study of Weekly Paclitaxel, Cisplatin and Concurrent Radiation Therapy for Locally-Advanced Unresectable Non-Small Cell Lung Cancer: Early Closure due to Lack of Efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase II Study of Weekly Paclitaxel, Cisplatin and Concurrent Radiation Therapy for Locally-Advanced Unresectable Non-Small Cell Lung Cancer: Early Closure due to Lack of Efficacy

Published:2004 Issue:5 Volume:36 Page:293
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Park Se Hoon¹,Kim Mi Kyung¹,Kyung Sun Young¹,Lim Young-Hee¹,An Chang Hyeok¹,Park Jeong Woong¹,Jeong Seong Hwan¹,Lee Jae Woong²,Lee Kyu Chan³,Cho Eun Kyung¹,Bang Soo Mee¹,Shin Dong Bok¹,Lee Jae Hoon¹

Affiliation:

1. Department of Internal Medicine, Gachon Medical School Gil Medical Center, Incheon, Korea.

2. Department of Thoracic Surgery, Gachon Medical School Gil Medical Center, Incheon, Korea.

3. Department of Radiation Oncology, Gachon Medical School Gil Medical Center, Incheon, Korea.

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-36-293.pdf

Reference23 articles.

1. Five-Year Survival After Hyperfractionated Radiation Therapy for Non-Small-Cell Carcinoma of the Lung (NSCCL)

2. Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

3. Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

4. Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP